Growing antecedents reported in the literature indicate that elevated circulating inflammatory markers, such as C-reactive protein (CRP), predict coronary events, stroke, and progression of peripheral disease independent of the severity of atherosclerotic or ischemic events (Pepys and Hirschfield, 2003). This evidence concerns the gene CRP and stroke disorder.